JP2014509860A5 - - Google Patents

Download PDF

Info

Publication number
JP2014509860A5
JP2014509860A5 JP2013558453A JP2013558453A JP2014509860A5 JP 2014509860 A5 JP2014509860 A5 JP 2014509860A5 JP 2013558453 A JP2013558453 A JP 2013558453A JP 2013558453 A JP2013558453 A JP 2013558453A JP 2014509860 A5 JP2014509860 A5 JP 2014509860A5
Authority
JP
Japan
Prior art keywords
antibody
antibody according
seq
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013558453A
Other languages
English (en)
Japanese (ja)
Other versions
JP6220675B2 (ja
JP2014509860A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/054629 external-priority patent/WO2012123562A1/en
Publication of JP2014509860A publication Critical patent/JP2014509860A/ja
Publication of JP2014509860A5 publication Critical patent/JP2014509860A5/ja
Application granted granted Critical
Publication of JP6220675B2 publication Critical patent/JP6220675B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013558453A 2011-03-16 2012-03-16 診断用抗体アッセイ Expired - Fee Related JP6220675B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161453449P 2011-03-16 2011-03-16
US61/453,449 2011-03-16
PCT/EP2012/054629 WO2012123562A1 (en) 2011-03-16 2012-03-16 Diagnostic antibody assay

Publications (3)

Publication Number Publication Date
JP2014509860A JP2014509860A (ja) 2014-04-24
JP2014509860A5 true JP2014509860A5 (https=) 2015-04-23
JP6220675B2 JP6220675B2 (ja) 2017-11-01

Family

ID=45833428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013558453A Expired - Fee Related JP6220675B2 (ja) 2011-03-16 2012-03-16 診断用抗体アッセイ

Country Status (15)

Country Link
US (2) US8809508B2 (https=)
EP (1) EP2686346B1 (https=)
JP (1) JP6220675B2 (https=)
KR (1) KR102020072B1 (https=)
CN (1) CN103459421B (https=)
AU (1) AU2012228236B2 (https=)
BR (1) BR112013023211B1 (https=)
CA (1) CA2828433C (https=)
DK (1) DK2686346T3 (https=)
EA (1) EA032054B1 (https=)
IL (1) IL227847A0 (https=)
MX (1) MX343873B (https=)
SG (1) SG192805A1 (https=)
WO (1) WO2012123562A1 (https=)
ZA (1) ZA201305946B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX367855B (es) 2013-03-15 2019-09-09 Probiodrug Ag Inhibidores novedosos.
JP2018501482A (ja) 2014-12-19 2018-01-18 プロビオドルグ エージー pGlu−Abetaペプチドの検出のための新規の方法
EP3262070A4 (en) * 2015-02-24 2018-07-25 Rpeptide, LLC Anti-amyloid-beta antibodies
CA2992386A1 (en) * 2015-07-16 2017-01-19 Probiodrug Ag Humanized antibodies
GB201910697D0 (en) * 2019-07-26 2019-09-11 Binding Site Group Ltd Lonisation control
JP2022550017A (ja) * 2019-10-01 2022-11-30 レプリゲン・コーポレーション 流体におけるタンパク質濃度の決定
KR102790945B1 (ko) * 2022-09-23 2025-04-04 경성대학교 산학협력단 베타-아밀로이드 42를 이용한 치매 진단 방법 및 이를 이용한 치매 진단 키트
CN121253823A (zh) * 2025-10-10 2026-01-02 山东九嘉生物科技有限公司 一种用于检测胃蛋白酶原ⅰ的化学发光试剂盒及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
EP1237930B1 (en) * 1999-12-08 2006-11-08 Intellect Neurosciences, Inc. Chimeric amyloid beta peptides
US7117096B2 (en) * 2001-04-17 2006-10-03 Abmaxis, Inc. Structure-based selection and affinity maturation of antibody library
WO2004013172A2 (en) 2002-07-24 2004-02-12 Innogenetics N.V. Fragments of beta-amyloid as targets for vaccination against alzheimer disease
WO2004029629A1 (en) 2002-09-27 2004-04-08 Janssen Pharmaceutica N.V. N-11 truncated amyloid-beta nomoclonal antibodies, compositions, methods and uses
CA2554809C (en) 2004-02-05 2014-04-29 Probiodrug Ag Novel n-alkyl thiourea- and thioamide-substituted imidazolyl inhibitors of glutaminyl cyclase
ES2259270B1 (es) 2005-03-09 2007-11-01 Consejo Superior De Investigaciones Cientificas Metodo de diagnostico in vitro de la enfermedad de alzheimer mediante un anticuerpo monoclonal.
US20100028351A1 (en) 2006-06-29 2010-02-04 Marc Mercken Anti-amyloid antibodies, compositions, methods and uses
WO2008055947A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ES2481442T3 (es) 2006-11-09 2014-07-30 Probiodrug Ag Inhibidores novedosos de glutaminil ciclasa
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
JP5612860B2 (ja) 2007-03-09 2014-10-22 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのイミダゾ[1,5−a]ピリジン誘導体
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
DK2160389T3 (da) 2007-04-18 2014-06-23 Probiodrug Ag Thioxoquinazolinonderivater som glutaminylcyclaseinhibitorer
EP2160380B1 (en) 2007-04-18 2014-04-02 Probiodrug AG Cyano-guanidine derivatives as glutaminyl cyclase inhibitors
WO2008128986A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Urea derivatives as glutaminyl cyclase inhibitors
ES2468551T3 (es) 2007-04-18 2014-06-16 Probiodrug Ag Derivados de nitrovinil-diamina como inhibidores de la glutaminil ciclasa
WO2008128984A1 (en) 2007-04-20 2008-10-30 Probiodrug Ag Aminopyrimidine derivatives as glutaminyl cyclase inhibitors
US20100074901A1 (en) * 2007-10-15 2010-03-25 Marc Hubert Mercken Human anti-amyloid antibodies, compositions, methods and uses
AT506820B1 (de) * 2008-06-12 2011-07-15 Affiris Forschungs Und Entwicklungs Gmbh Vakzine gegen alzheimer-krankheit
WO2010009987A2 (en) * 2008-07-21 2010-01-28 Probiodrug Ag Diagnostic antibody assay
WO2010128139A1 (en) * 2009-05-08 2010-11-11 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Biomarkers and methods for diagnosing alzheimer's disease and/ or mild cognitive impairment
LT2448968T (lt) * 2009-06-29 2021-05-10 Bioarctic Ab Antikūnai, atpažįstantys n gale sutrumpintas amiloido protofibriles/oligomerus

Similar Documents

Publication Publication Date Title
JP2014509860A5 (https=)
JP2011528561A5 (https=)
KR101982899B1 (ko) TL1a에 대한 항체 및 그의 용도
CA2861793C (en) Method of providing monoclonal auto-antibodies with desired specificity
JP2016516400A5 (https=)
JP2013506428A5 (https=)
JP2009518005A5 (https=)
JP2015535820A5 (https=)
RS53270B2 (sr) Monoklonalna antitela protiv amiloidnog beta proteina i njihova upotreba
IL186948A0 (en) Monoclonal antibodies and methods for their use in the detection of cervical disease
HRP20191342T1 (hr) Anti-phf-tau antitijela i njihove upotrebe
JP2011511624A5 (https=)
JP2016020389A5 (https=)
JP2010536384A5 (https=)
JP2014518883A5 (https=)
JP2011173884A5 (https=)
JP2016531546A5 (https=)
JP6744857B2 (ja) 生物学的材料およびその用途
JP2013542914A5 (https=)
JP2013539369A5 (https=)
EP2997162A2 (en) Methods for diagnosing and treating inflammatory bowel disease
TR201903026T4 (en) S100A4 ANTIBODIES AND THEIR THERAPEUTIC USES.
WO2014106235A1 (en) Anti-granulysin antibodies and methods of use thereof
RU2014106933A (ru) Способы и композиции для лечения аутоиммунных и воспалительных заболеваний
RU2017139800A (ru) Комбинированный препарат антител против staphylococcus aureus